Management of severe acute exacerbations of COPD: an updated narrative review

[1]  J. Morrison,et al.  Early , 2020, Journal of Roman Studies.

[2]  N. Team.  Chronic obstructive pulmonary disease in over 16s: diagnosis and management , 2018 .

[3]  A. Esquinas,et al.  High flow nasal cannulae versus non‐invasive ventilation in moderate hypercapnic respiratory failure: Different roads, same destination but doubtful equality , 2018, The clinical respiratory journal.

[4]  A. Torres,et al.  Microorganisms resistant to conventional antimicrobials in acute exacerbations of chronic obstructive pulmonary disease , 2018, Respiratory Research.

[5]  M. Montes de Oca,et al.  Is It Time to Change the Definition of Acute Exacerbation of Chronic Obstructive Pulmonary Disease? What Do We Need to Add? , 2018, Medical sciences.

[6]  S. Yong,et al.  High flow nasal cannulae oxygen therapy in acute‐moderate hypercapnic respiratory failure , 2018, The clinical respiratory journal.

[7]  E. Clini,et al.  Ultrasound-assessed diaphragmatic impairment is a predictor of outcomes in patients with acute exacerbation of chronic obstructive pulmonary disease undergoing noninvasive ventilation , 2018, Critical Care.

[8]  A. Anzueto,et al.  Treatment of exacerbations as a predictor of subsequent outcomes in patients with COPD , 2018, International journal of chronic obstructive pulmonary disease.

[9]  A. Amin,et al.  Treatment patterns for patients hospitalized with chronic obstructive pulmonary disease , 2018, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[10]  S. Loukides,et al.  Ability of using different dry powder inhalers during COPD exacerbations. , 2018, Pulmonary pharmacology & therapeutics.

[11]  M. Etminan,et al.  The association between previous and future severe exacerbations of chronic obstructive pulmonary disease: Updating the literature using robust statistical methodology , 2018, PloS one.

[12]  Sally J. Singh,et al.  Pulmonary rehabilitation for patients with COPD during and after an exacerbation-related hospitalisation: back to the future? , 2018, European Respiratory Journal.

[13]  T. Geiser,et al.  Efficacy and safety of nasal high-flow oxygen in COPD patients , 2017, BMC Pulmonary Medicine.

[14]  Michel Wolff,et al.  Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. , 2017, The Cochrane database of systematic reviews.

[15]  Zhi-hong Lin,et al.  Does high-flow nasal cannula oxygen improve outcome in acute hypoxemic respiratory failure? A systematic review and meta-analysis. , 2017, Respiratory medicine.

[16]  M. Mantero,et al.  Acute exacerbations of COPD: risk factors for failure and relapse , 2017, International journal of chronic obstructive pulmonary disease.

[17]  R. Rodríguez-Roisín,et al.  Multi-level differential network analysis of COPD exacerbations , 2017, European Respiratory Journal.

[18]  B. Celli.  Dissecting COPD exacerbations: time to rethink our definition , 2017, European Respiratory Journal.

[19]  S. Keenan,et al.  Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure , 2017, European Respiratory Journal.

[20]  Joanna Picot,et al.  Non-invasive ventilation for the management of acute hypercapnic respiratory failure due to exacerbation of chronic obstructive pulmonary disease. , 2017, The Cochrane database of systematic reviews.

[21]  N. Marjanovic,et al.  High-flow nasal oxygen therapy and noninvasive ventilation in the management of acute hypoxemic respiratory failure. , 2017, Annals of translational medicine.

[22]  P. Jolliet,et al.  Noninvasive ventilation with helium–oxygen mixture in hypercapnic COPD exacerbation: aggregate meta-analysis of randomized controlled trials , 2017, Annals of Intensive Care.

[23]  J. Fraser,et al.  High-flow nasal cannulae for respiratory support in adult intensive care patients. , 2017, The Cochrane database of systematic reviews.

[24]  S. Bibby,et al.  Physiological effects of titrated oxygen via nasal high‐flow cannulae in COPD exacerbations: A randomized controlled cross‐over trial , 2017, Respirology.

[25]  J. Chiche,et al.  A Multicenter Randomized Trial Assessing the Efficacy of Helium/Oxygen in Severe Exacerbations of Chronic Obstructive Pulmonary Disease , 2017, American journal of respiratory and critical care medicine.

[26]  A. Torres,et al.  Noninvasive Ventilation with Helium/Oxygen in Chronic Obstructive Pulmonary Disease Exacerbations. When Physiologic Improvement Does Not Translate into Clinical Benefit. , 2017, American journal of respiratory and critical care medicine.

[27]  John R. Hurst,et al.  Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline , 2017, European Respiratory Journal.

[28]  I. Torres-Sánchez,et al.  Physical and Functional Impairment During and After Hospitalization in Subjects With Severe COPD Exacerbation , 2017, Respiratory Care.

[29]  I. Torres-Sánchez,et al.  Effects of an Exercise Intervention in Frail Older Patients with Chronic Obstructive Pulmonary Disease Hospitalized due to an Exacerbation: A Randomized Controlled Trial , 2017, COPD.

[30]  S. Ginsburg,et al.  Bronchodilator Delivery in Acute Airflow Obstruction , 2017 .

[31]  Youjin Lu,et al.  A randomized, controlled multicentric study of inhaled budesonide and intravenous methylprednisolone in the treatment on acute exacerbation of chronic obstructive pulmonary disease. , 2016, Respiratory medicine.

[32]  K. Carriere,et al.  Effects of long-term bronchodilators in bronchiectasis patients with airflow limitation based on bronchodilator response at baseline , 2016, International journal of chronic obstructive pulmonary disease.

[33]  D. Slebos,et al.  Bronchodilators delivered by nebuliser versus pMDI with spacer or DPI for exacerbations of COPD. , 2016, The Cochrane database of systematic reviews.

[34]  Y. Lacasse,et al.  Automated oxygen titration and weaning with FreeO2 in patients with acute exacerbation of COPD: a pilot randomized trial , 2016, International journal of chronic obstructive pulmonary disease.

[35]  H. Park,et al.  Comorbidity as a contributor to frequent severe acute exacerbation in COPD patients , 2016, International journal of chronic obstructive pulmonary disease.

[36]  S. Mojal,et al.  Impact of hyponatremia on mortality and morbidity in patients with COPD exacerbations. , 2016, Respiratory medicine.

[37]  B. Cao,et al.  Acute exacerbations of chronic obstructive pulmonary disease with low serum procalcitonin values do not benefit from antibiotic treatment: a prospective randomized controlled trial. , 2016, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[38]  A. Chetta,et al.  Readmission in COPD patients: should we consider it a marker of quality of care or a marker of a more severe disease with a worse prognosis? , 2016, European Respiratory Journal.

[39]  M. Santibáñez,et al.  Predictors of Hospitalized Exacerbations and Mortality in Chronic Obstructive Pulmonary Disease , 2016, PloS one.

[40]  S. Kon,et al.  Physical frailty and pulmonary rehabilitation in COPD: a prospective cohort study , 2016, Thorax.

[41]  J. Bräunlich,et al.  Nasal highflow improves ventilation in patients with COPD , 2016, International journal of chronic obstructive pulmonary disease.

[42]  J. Wedzicha,et al.  Indacaterol-Glycopyrronium versus Salmeterol-Fluticasone for COPD. , 2016, The New England journal of medicine.

[43]  J. Wells,et al.  Pulmonary Artery Enlargement Is Associated With Cardiac Injury During Severe Exacerbations of COPD. , 2016, Chest.

[44]  Zhilong Jiang,et al.  Update on molecular mechanisms of corticosteroid resistance in chronic obstructive pulmonary disease. , 2016, Pulmonary pharmacology & therapeutics.

[45]  F. Fabbian,et al.  Impact of renal dysfunction on in-hospital mortality of patients with severe chronic obstructive pulmonary disease: a single-center Italian study , 2016, International Urology and Nephrology.

[46]  Antoni Torres,et al.  Readmission for Acute Exacerbation within 30 Days of Discharge Is Associated with a Subsequent Progressive Increase in Mortality Risk in COPD Patients: A Long-Term Observational Study , 2016, PloS one.

[47]  J. Bourbeau,et al.  Early COPD Exacerbation Treatment with Combination of ICS and LABA for Patients Presenting with Mild-to-Moderate Worsening of Dyspnea , 2016, COPD.

[48]  J. Wedzicha,et al.  Predicting In-Hospital Treatment Failure (≤7 days) in Patients with COPD Exacerbation Using Antibiotics and Systemic Steroids , 2016, COPD.

[49]  Peiheng He,et al.  Efficacy and Safety of Tranexamic Acid in Bilateral Total Knee Replacement: A Meta-Analysis and Systematic Review , 2015, Medical science monitor : international medical journal of experimental and clinical research.

[50]  A. Torres,et al.  Predictors of Readmission in a Period of 30 Days or Less in Acute Exacerbation of Chronic Obstructive Pulmonary Disease , 2015 .

[51]  Yi‐Jen Chen,et al.  Severe hypoalbuminemia is a strong independent risk factor for acute respiratory failure in COPD: a nationwide cohort study , 2015, International journal of chronic obstructive pulmonary disease.

[52]  A. Liapikou,et al.  C-Reactive Protein at Discharge, Diabetes Mellitus and ≥1 Hospitalization During Previous Year Predict Early Readmission in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease , 2015, COPD.

[53]  M. Çakır,et al.  Do females behave differently in COPD exacerbation? , 2015, International journal of chronic obstructive pulmonary disease.

[54]  Alvar Agusti,et al.  Hospitalized exacerbations of COPD: risk factors and outcomes in the ECLIPSE cohort. , 2015, Chest.

[55]  Zhongmin Qiu,et al.  Efficiency and Safety of Pulmonary Rehabilitation in Acute Exacerbation of Chronic Obstructive Pulmonary Disease , 2015, Medical science monitor : international medical journal of experimental and clinical research.

[56]  M. Aliyali,et al.  Impact of Comorbid Ischemic Heart Disease on Short-Term Outcomes of Patients Hospitalized for Acute Exacerbations of COPD , 2015, Tanaffos.

[57]  J. Walters,et al.  Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease. , 2014, The Cochrane database of systematic reviews.

[58]  C. Mega,et al.  Oronasal mask versus helmet in acute hypercapnic respiratory failure , 2014, European Respiratory Journal.

[59]  A. Nicolini,et al.  Open-Mouthpiece Ventilation Versus Nasal Mask Ventilation in Subjects With COPD Exacerbation and Mild to Moderate Acidosis: A Randomized Trial , 2014, Respiratory Care.

[60]  A. Torres,et al.  Inhaled Corticosteroids Do Not Influence the Early Inflammatory Response and Clinical Presentation of Hospitalized Subjects With COPD Exacerbation , 2014, Respiratory Care.

[61]  R. C. Borges,et al.  Impact of resistance training in chronic obstructive pulmonary disease patients during periods of acute exacerbation. , 2014, Archives of physical medicine and rehabilitation.

[62]  Sally J. Singh,et al.  An early rehabilitation intervention to enhance recovery during hospital admission for an exacerbation of chronic respiratory disease: randomised controlled trial , 2014, BMJ : British Medical Journal.

[63]  Y. Kuo,et al.  Predictors of early readmission among patients 40 to 64 years of age hospitalized for chronic obstructive pulmonary disease. , 2014, Annals of the American Thoracic Society.

[64]  J. Wedzicha,et al.  Daily activity during stability and exacerbation of chronic obstructive pulmonary disease , 2014, BMC Pulmonary Medicine.

[65]  R. Vandivier,et al.  Outcomes associated with corticosteroid dosage in critically ill patients with acute exacerbations of chronic obstructive pulmonary disease. , 2014, American journal of respiratory and critical care medicine.

[66]  E. Clini,et al.  Rehabilitation and supportive therapy in elderly patients with Chronic Obstructive Pulmonary Disease. , 2014, European journal of internal medicine.

[67]  A. Sayıner,et al.  Comparison of two systemic steroid regimens for the treatment of COPD exacerbations. , 2014, Pulmonary pharmacology & therapeutics.

[68]  Mark V. Williams,et al.  Interventions to reduce rehospitalizations after chronic obstructive pulmonary disease exacerbations. A systematic review. , 2014, Annals of the American Thoracic Society.

[69]  M. Cazzola,et al.  Effect of indacaterol on arterial blood gases in patients suffering from acute exacerbation of COPD. , 2014, Respiratory medicine.

[70]  C. Pitoyo,et al.  Non-invasive ventilation in acute respiratory failure. , 2014, Acta medica Indonesiana.

[71]  M. Cazzola,et al.  The effect of indacaterol during an acute exacerbation of COPD. , 2013, Pulmonary Pharmacology & Therapeutics.

[72]  V. Rahimi-Movaghar,et al.  The Adjunctive Effect of Nebulized Furosemide in COPD Exacerbation: A Randomized Controlled Clinical Trial , 2013, Respiratory Care.

[73]  Thierry Troosters,et al.  An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. , 2013, American journal of respiratory and critical care medicine.

[74]  A. Torres,et al.  Pneumonic and nonpneumonic exacerbations of COPD: inflammatory response and clinical characteristics. , 2013, Chest.

[75]  Sally J. Singh,et al.  Neuromuscular stimulation of quadriceps in patients hospitalised during an exacerbation of COPD: a comparison of low (35 Hz) and high (50 Hz) frequencies. , 2013, Physiotherapy research international : the journal for researchers and clinicians in physical therapy.

[76]  F. Dachraoui,et al.  Prednisone in COPD exacerbation requiring ventilatory support: an open-label randomised evaluation , 2013, European Respiratory Journal.

[77]  M. Briel,et al.  Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial. , 2013, JAMA.

[78]  James D. Chalmers,et al.  Predictors of mortality in hospitalized adults with acute exacerbation of chronic obstructive pulmonary disease. , 2013, Annals of the American Thoracic Society.

[79]  S. Antoniu,et al.  Hospitalizations for chronic obstructive pulmonary disease exacerbations and their impact on disease and subsequent morbidity and mortality , 2013, Expert review of pharmacoeconomics & outcomes research.

[80]  Jordi Rello,et al.  Effect of High-Flow Nasal Cannula and Body Position on End-Expiratory Lung Volume: A Cohort Study Using Electrical Impedance Tomography , 2013, Respiratory Care.

[81]  J. Vonk,et al.  Day-to-day measurement of patient-reported outcomes in exacerbations of chronic obstructive pulmonary disease , 2013, International journal of chronic obstructive pulmonary disease.

[82]  D. Mannino,et al.  Outcomes of noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease in the United States, 1998-2008. , 2012, American journal of respiratory and critical care medicine.

[83]  W. MacNee,et al.  Neuromuscular electrical stimulation prevents muscle function deterioration in exacerbated COPD: a pilot study. , 2012, Respiratory medicine.

[84]  S. Suissa,et al.  Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality , 2012, Thorax.

[85]  Yu-Chung Wu,et al.  Spontaneous breathing trial needs to be prolonged in critically ill and older patients requiring mechanical ventilation. , 2012, Journal of critical care.

[86]  D. Dreyfuss,et al.  Impact of high-flow nasal cannula oxygen therapy on intensive care unit patients with acute respiratory failure: a prospective observational study. , 2012, Journal of critical care.

[87]  F. Blackstock,et al.  Early Rehabilitation Exercise Program for Inpatients During an Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A RANDOMIZED CONTROLLED TRIAL , 2012, Journal of cardiopulmonary rehabilitation and prevention.

[88]  N. Ambrosino,et al.  Exercise performance after standard rehabilitation in COPD patients with lung hyperinflation , 2014, Internal and Emergency Medicine.

[89]  A. Anzueto,et al.  Efficacy of corticosteroid therapy in patients with an acute exacerbation of chronic obstructive pulmonary disease receiving ventilatory support. , 2011, Archives of internal medicine.

[90]  S. Nava,et al.  Optimization of ventilator setting by flow and pressure waveforms analysis during noninvasive ventilation for acute exacerbations of COPD: a multicentric randomized controlled trial , 2011, Critical care.

[91]  M. Miravitlles,et al.  Sputum colour and bacteria in chronic bronchitis exacerbations: a pooled analysis , 2011, European Respiratory Journal.

[92]  D. Dreyfuss,et al.  Beneficial effects of humidified high flow nasal oxygen in critical care patients: a prospective pilot study , 2011, Intensive Care Medicine.

[93]  S. Zakynthinos,et al.  Effect of pulmonary rehabilitation on peripheral muscle fiber remodeling in patients with COPD in GOLD stages II to IV. , 2011, Chest.

[94]  R. Garrod,et al.  Determinants of success , 2011, European Respiratory Journal.

[95]  N. Wig,et al.  Efficacy of two corticosteroid regimens in acute exacerbation of chronic obstructive pulmonary disease. , 2011, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[96]  D. Mannino,et al.  Lung function impairment, COPD hospitalisations and subsequent mortality , 2011, Thorax.

[97]  W. Zin,et al.  Comparison of Noninvasive Ventilation by Sequential Use of Mask and Helmet versus Mask in Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Preliminary Study , 2011, Respiration.

[98]  Meilan K. Han,et al.  Randomized Trial of Zileuton for Treatment of COPD Exacerbations Requiring Hospitalization , 2011, COPD.

[99]  J. Barker.  A multicenter, randomized trial of noninvasive ventilation with helium-oxygen mixture in exacerbations of chronic obstructive lung disease , 2011 .

[100]  E. Clini,et al.  Rehabilitation in COPD patients admitted for exacerbation. , 2011, Pneumonologia i alergologia polska.

[101]  C. Roberts,et al.  Acidosis, non-invasive ventilation and mortality in hospitalised COPD exacerbations , 2010, Thorax.

[102]  R. Wood‐Baker,et al.  Effect of high flow oxygen on mortality in chronic obstructive pulmonary disease patients in prehospital setting: randomised controlled trial , 2010, BMJ : British Medical Journal.

[103]  J. Wedzicha,et al.  Susceptibility to exacerbation in chronic obstructive pulmonary disease. , 2010, The New England journal of medicine.

[104]  S. Zakynthinos,et al.  Effect of pulmonary rehabilitation on muscle remodelling in cachectic patients with COPD , 2010, European Respiratory Journal.

[105]  F. Abroug,et al.  Standard versus newer antibacterial agents in the treatment of severe acute exacerbation of chronic obstructive pulmonary disease: a randomized trial of trimethoprim-sulfamethoxazole versus ciprofloxacin. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[106]  R. Hoogenveen,et al.  Case fatality of COPD exacerbations: a meta-analysis and statistical modelling approach , 2010, European Respiratory Journal.

[107]  E. Clini,et al.  Measures of dyspnea in pulmonary rehabilitation , 2010, Multidisciplinary respiratory medicine.

[108]  P. Lindenauer,et al.  Association of corticosteroid dose and route of administration with risk of treatment failure in acute exacerbation of chronic obstructive pulmonary disease. , 2010, JAMA.

[109]  M. Decramer,et al.  Resistance training prevents deterioration in quadriceps muscle function during acute exacerbations of chronic obstructive pulmonary disease. , 2010, American journal of respiratory and critical care medicine.

[110]  E. Clini,et al.  Early rehabilitation: much better than nothing. , 2010, American journal of respiratory and critical care medicine.

[111]  L. Fabbri,et al.  Efficacy of standard rehabilitation in COPD outpatients with comorbidities , 2010, European Respiratory Journal.

[112]  A. Evensen.  Management of COPD exacerbations. , 2010, American family physician.

[113]  W. Boersma,et al.  Antibiotics in addition to systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. , 2010, American journal of respiratory and critical care medicine.

[114]  N. Ambrosino,et al.  Effects of early inpatient rehabilitation after acute exacerbation of COPD. , 2009, Respiratory medicine.

[115]  T. Bregenzer,et al.  Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. , 2009, JAMA.

[116]  D. Brooks,et al.  Pulmonary Rehabilitation After Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Patients Who Previously Completed a Pulmonary Rehabilitation Program , 2009, Journal of cardiopulmonary rehabilitation and prevention.

[117]  A. Agustí,et al.  A controlled trial of noninvasive ventilation for chronic obstructive pulmonary disease exacerbations. , 2009, Journal of critical care.

[118]  P. Poole,et al.  Does early pulmonary rehabilitation reduce acute health‐care utilization in COPD patients admitted with an exacerbation? A randomized controlled study , 2009, Respirology.

[119]  E. Clini,et al.  Exercise Capacity as a Pulmonary Rehabilitation Outcome , 2009, Respiration.

[120]  Stefano Nava,et al.  Interfaces and humidification for noninvasive mechanical ventilation. , 2009, Respiratory care.

[121]  T. Murphy,et al.  Infection in the pathogenesis and course of chronic obstructive pulmonary disease. , 2008, The New England journal of medicine.

[122]  L. Fabbri,et al.  Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation , 2008, Thorax.

[123]  D. Postma,et al.  Oral or IV prednisolone in the treatment of COPD exacerbations: a randomized, controlled, double-blind study. , 2007, Chest.

[124]  T. Seemungal,et al.  COPD exacerbations: defining their cause and prevention , 2007, The Lancet.

[125]  B. Celli,et al.  Exacerbations of chronic obstructive pulmonary disease , 2007, European Respiratory Journal.

[126]  M. Christ-Crain,et al.  Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy. , 2007, Chest.

[127]  P. Calverley,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.

[128]  R. Rodríguez-Roisín,et al.  Antibiotics for exacerbations of chronic obstructive pulmonary disease. , 2011, The Cochrane database of systematic reviews.

[129]  J. Abreu González,et al.  [Effect of intravenous magnesium sulfate on chronic obstructive pulmonary disease exacerbations requiring hospitalization: a randomized placebo-controlled trial]. , 2006, Archivos de bronconeumologia.

[130]  John R Hurst,et al.  Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease. , 2006, American journal of respiratory and critical care medicine.

[131]  Concepción Hernández García,et al.  Efecto del sulfato de magnesio intravenoso en la exacerbación de la EPOC que precisa hospitalización: estudio aleatorizado controlado con placebo , 2006 .

[132]  M. Antonelli,et al.  A chart of failure risk for noninvasive ventilation in patients with COPD exacerbation , 2005, European Respiratory Journal.

[133]  A. Pont,et al.  Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study , 2004, Thorax.

[134]  R. Pauwels,et al.  COPD exacerbations: the importance of a standard definition. , 2004, Respiratory medicine.

[135]  M. Decramer,et al.  CHRONIC OBSTRUCTIVE PULMONARY DISEASE Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I , 2003 .

[136]  M. Cazzola,et al.  Long-acting β2 agonists as potential option in the treatment of acute exacerbations of COPD , 2003 .

[137]  S. Spencer,et al.  Time course of recovery of health status following an infective exacerbation of chronic bronchitis , 2003, Thorax.

[138]  I. Stiell,et al.  Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease. , 2003, The New England journal of medicine.

[139]  S. Parrott,et al.  Cost effectiveness of ward based non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease: economic analysis of randomised controlled trial , 2003, BMJ : British Medical Journal.

[140]  J. Wedzicha,et al.  Non-invasive positive pressure ventilation to treat respiratory failure resulting from exacerbations of chronic obstructive pulmonary disease: Cochrane systematic review and meta-analysis , 2003, BMJ : British Medical Journal.

[141]  Andrew J. White,et al.  Chronic obstructive pulmonary disease • 6: The aetiology of exacerbations of chronic obstructive pulmonary disease , 2003, Thorax.

[142]  G. Liistro,et al.  Noninvasive ventilation for acute respiratory failure: a prospective randomised placebo-controlled trial , 2002, European Respiratory Journal.

[143]  F. Maltais,et al.  Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial. , 2002, American journal of respiratory and critical care medicine.

[144]  F. Abroug,et al.  Once daily oral ofloxacin in chronic obstructive pulmonary disease exacerbation requiring mechanical ventilation: a randomised placebo-controlled trial , 2001, The Lancet.

[145]  R. Masterton,et al.  Randomized, double-blind study comparing 5- and 7-day regimens of oral levofloxacin in patients with acute exacerbation of chronic bronchitis. , 2001, International journal of antimicrobial agents.

[146]  M. Elliott,et al.  Non-invasive ventilation in acute exacerbations of chronic obstructive pulmonary disease: long term survival and predictors of in-hospital outcome , 2001, Thorax.

[147]  M. Cirit,et al.  Systemic glucocorticoids in severe exacerbations of COPD. , 2001, Chest.

[148]  M. Elliott,et al.  One year period prevalence study of respiratory acidosis in acute exacerbations of COPD: implications for the provision of non-invasive ventilation and oxygen administration , 2000, Thorax.

[149]  P. Plant,et al.  Early use of non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease on general respiratory wards: a multicentre randomised controlled trial , 2000, The Lancet.

[150]  S. Jaber,et al.  Noninvasive ventilation with helium-oxygen in acute exacerbations of chronic obstructive pulmonary disease. , 2000, American journal of respiratory and critical care medicine.

[151]  J. Costantino,et al.  A randomized, prospective evaluation of noninvasive ventilation for acute respiratory failure. , 2000, American journal of respiratory and critical care medicine.

[152]  L. Davies,et al.  Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial , 1999, The Lancet.

[153]  D. Niewoehner,et al.  Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group. , 1999, The New England journal of medicine.

[154]  M. Sungur,et al.  Comparison of noninvasive positive pressure ventilation with standard medical therapy in hypercapnic acute respiratory failure. , 1998, Chest.

[155]  R. Rodríguez-Roisín,et al.  Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. , 1998, American journal of respiratory and critical care medicine.

[156]  J. M. FitzGerald,et al.  Bronchodilator delivery in acute airflow obstruction. A meta-analysis. , 1997, Archives of internal medicine.

[157]  M. Wysocki,et al.  Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease. , 1995, The New England journal of medicine.

[158]  S. Nava,et al.  Non-invasive mechanical ventilation in acute respiratory failure due to chronic obstructive pulmonary disease: correlates for success. , 1995, Thorax.

[159]  N. Hill,et al.  Randomized, prospective trial of noninvasive positive pressure ventilation in acute respiratory failure. , 1995, American journal of respiratory and critical care medicine.

[160]  J. Wedzicha,et al.  Randomised controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive airways disease , 1993, The Lancet.

[161]  A. Jl,et al.  Antibiotic treatment for acute episodes of chronic obstructive pulmonary disease , 1992 .

[162]  D. Flenley,et al.  Acute hypercapnic respiratory failure in patients with chronic obstructive lung disease: risk factors and use of guidelines for management. , 1992, Thorax.

[163]  M. T. Rubio Obanos,et al.  [Antibiotic treatment for acute episodes of chronic obstructive pulmonary disease]. , 1992, Anales de medicina interna.

[164]  N. Anthonisen,et al.  Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. , 1987, Annals of internal medicine.

[165]  H. Raafat,et al.  Antibiotic regimens in moderately ill patients with purulent exacerbations of chronic bronchitis. , 1972, British journal of diseases of the chest.

[166]  H. Raafat,et al.  Antibiotic regimens in severe and acute purulent exacerbations of chronic bronchitis. , 1968, British medical journal.